IM Cannabis Corp. (IMCC)
| Previous Close | 2.6100 |
| Open | 2.6400 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 2.4500 - 2.6550 |
| 52 Week Range | 1.1340 - 8.1000 |
| Volume | |
| Avg. Volume | 17,143 |
| Market Cap | 7.811M |
| Beta (5Y Monthly) | 1.68 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.1300 |
| Earnings Date | Nov 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupIM Cannabis Reports Third Quarter Financial Results
IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the third quarter ended September 30, 2024. All amounts are reported in Canadian dollars and compared to the quarter ended September 30, 2023, unless otherwise stated.
- CNW Group
IM Cannabis Closes Non-Brokered Private Placement led by Management and Concurrent Debt Settlement
IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further to its press release dated October 4, 2024 (the "October 4 Release"), the Company has closed its previously announced non-brokered private placement offering (the "Offering") effective today (the "Closing Date") through the issuance of 742,517 Units for gross proceed of C$2,138,448.96. Capitalized terms not o
